Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 1 (2004), Issue 3 (November)

1. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results.
   Radiology, 233(2): 531-40. [Abstract] [Full-text]
2. Endogenous task shift processes in relapsing-remitting multiple sclerosis.
   Brain Cogn, 56(3): 328-31. [Abstract] [Full-text]
3. Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population.
   Mov Disord, 19(12): 1482-5. [Abstract] [Full-text]
4. No correlation between number of MRI-evident lesions in cerebrum and the soleus stretch reflex in multiple sclerosis patients.
   Eur J Neurol, 11(11): 760-6. [Abstract] [Full-text]
5. Relating neocortical pathology to disability progression in multiple sclerosis using MRI.
   Neuroimage, 23(3): 1168-75. [Abstract] [Full-text]
6. Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosis.
   Acta Neurol Scand, 110(6): 386-92. [Abstract] [Full-text]
7. CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis.
   Acta Neurol Scand, 110(6): 377-85. [Abstract] [Full-text]
8. New directions in MS therapeutics: vehicles of hope.
   Trends Immunol, 25(12): 632-6. [Abstract] [Full-text]
9. Dystonia in a 13-year-old boy with secondary progressive multiple sclerosis.
   Brain Dev, 26(8): 539-41. [Abstract] [Full-text]
10. The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone.
    Hum Mol Genet, 13(23): 2919-24. [Abstract] [Full-text]
11. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Clin Exp Immunol, 138(3): 499-506. [Abstract] [Full-text]
12. Multiple sclerosis after infectious mononucleosis: record linkage study.
    J Epidemiol Community Health, 58(12): 1032-5. [Abstract] [Full-text]
13. Environmental risk factors in multiple sclerosis aetiology.
    Lancet Neurol, 3(12): 709-18. [Abstract] [Full-text]
14. Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis.
    Eur Neurol, 52(3): 162-8. [Abstract] [Full-text]
15. Postpartum emotional distress in mothers with multiple sclerosis.
    J Obstet Gynecol Neonatal Nurs, 33(6): 729-38. [Abstract] [Full-text]
16. Aging with multiple sclerosis.
    Phys Med Rehabil Clin N Am, 16(1): 219-34. [Abstract] [Full-text]
17. IVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment.
    Brain, 127: 2649-56. [Abstract] [Full-text]
18. The relationship of APOE genetic polymorphism with susceptibility to multiple sclerosis and its clinical phenotypes in Kuwaiti Arab subjects.
    Clin Chim Acta, 351(1): 203-7. [Abstract] [Full-text]
19. Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis.
    J Neurosci Res, 78(5): 603-24. [Abstract] [Full-text]
20. Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody.
    Ann Neurol, 56(6): 864-7. [Abstract] [Full-text]
21. Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients.
    Ann Neurol, 56(6): 778-86. [Abstract] [Full-text]
22. Altered decision-making in multiple sclerosis: a sign of impaired emotional reactivity?
    Ann Neurol, 56(6): 787-95. [Abstract] [Full-text]
23. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
    Glia, 49(2): 220-9. [Abstract] [Full-text]

© 2004-2008 Multiple Sclerosis Research Today. All Rights Reserved.